Home >> Services >> All Other
 Global Parkinson’s disease Therapeutics Market
Posted on : Tuesday, 11 February, 2020  09:31
Location : Eisenstadt, Burgenland
Phone Number# : ---
URL : Website Link

Global Parkinson’s disease Therapeutics Market was valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2026, at CAGR of 11 % during forecast period of 2019 to 2026.
Parkinson's disease is a highly prevalent age-related neurodegenerative disorder, affecting millions of people worldwide and causing severe impact on their physical, psychological, as well as emotional health. It is largely prevalent among the geriatric population.
Global Parkinson’s disease Therapeutics Market by key segmentation
Oral route of administration, followed by intestinal infusion segment, dominates the global market. More than 80% of the drugs available for treatment of Parkinson's disease are in the form of tablet and capsule. Some of the drugs are orally disintegrated. Also, rise in adoption and demand for subcutaneous injections and promising pipeline products with subcutaneous route of administration for home management of Parkinson's disease are estimated to limit the growth of the oral route of administration segment by the end of 2026.
Retail pharmacy followed by hospital pharmacy segment, dominates the market. Among distribution channels, the retail pharmacy segment is projected to hold largest share of global market hold the dominant share of the global Parkinson's disease therapeutics market during the forecast period and is likely to expand the global market. Easy availability of Parkinson's therapeutic drugs at retail pharmacies, low price of the drugs, and expansion of leading retail pharmaceutical chains across the globe are driving the growth of the segment. The online pharmacy segment is poised to grow at as significant CAGR during the forecast period.
Global Parkinson’s disease Therapeutics Market by drivers and restraints
Recent advances in Parkinson’s disease therapeutics such as combination therapies to prolong the action of continuous dopaminergic stimulation drugs, approval for neurostimulation devices and neuroprotective therapies to slow down prognosis of a disease, gene therapy, neural transplantation etc., are expected to bring rapid growth in global Parkinson’s disease therapeutics market over the forecast period.

For More Information Visit @: https://www.maximizemarketresearch.com/market-report/global-parkinsons-disease-therapeutics-market/36272/
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact info:
Name: Lumawant Godage
Email: sales@maximizemarketresearch.com
Address: Pune, Maharashtra 411051, India.
Contact: +919607195908

  In this Ad : Offering a service
  Posted By: An Individual
  It is ok to contact this poster with commercial interests.

Home Browse Cities Sitemap Privacy Policy Disclaimer Contact Us

Copyright © 2014 Unolist LLC. All rights reserved.